Basis: Current FMP quote-based enterprise value / four-quarter revenue. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EV/Sales ratio high or low?
The EV/Sales ratio of 30.42x is 2231% above its estimated 5-year average of 1.31x, around the middle of its estimated 5-year range (0.00x–43.87x).
As of 2026-10-06T16:16:22.211Z. 173.42% above its estimated 12-month average of 11.13x.
Calculation as of: 2026-10-06T16:16:22.211Z.
Quote observation: 2026-10-06T16:15:20.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 7d2b810459fcea1e9aa106a928442b73bf826bd09a5c75c69395a3c454dfad86
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/SALES RATIO
30.42x
EV/SALES RATIO AVG TTM
11.13x
EV/SALES RATIO AVG 3Y
2.29x
EV/SALES RATIO AVG 5Y
1.31x
EV/SALES RATIO AVG 10Y
4.55x
EV/SALES RATIO AVG 15Y
N/A
EV/SALES RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+173.42%
CURRENT VS 3Y AVG
+1227.97%
CURRENT VS 5Y AVG
+2230.82%
CURRENT VS 10Y AVG
+568.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.20x
median of 473 covered companies
CURRENT VS SECTOR MEDIAN
+624.29%
vs the sector median at left
CytomX Therapeutics, Inc.
Market Cap
$568.20M
EV/Sales Ratio
30.42x
TTM Avg
11.13x
3Y Avg
2.29x
5Y Avg
1.31x
Market Cap
$566.38M
EV/Sales Ratio
0.98x
TTM Avg
2.91x
3Y Avg
806.84x
5Y Avg
1105.61x
Market Cap
$574.01M
EV/Sales Ratio
9.88x
TTM Avg
11.75x
3Y Avg
7.27x
5Y Avg
5.37x
Market Cap
$552.40M
EV/Sales Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$549.33M
EV/Sales Ratio
64.50x
TTM Avg
53.58x
3Y Avg
21.24x
5Y Avg
46.54x
Market Cap
$587.91M
EV/Sales Ratio
2.62x
TTM Avg
2.20x
3Y Avg
3.12x
5Y Avg
5.45x
Market Cap
$593.40M
EV/Sales Ratio
1.78x
TTM Avg
1.86x
3Y Avg
1.97x
5Y Avg
1.94x
| NAME | MARKET CAP | EV/SALES RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CytomX Therapeutics, Inc. (CTMX) | $568.20M | 30.42x | 11.13x | 2.29x | 1.31x |
| CorMedix Inc. (CRMD)vs › | $566.38M | 0.98x | 2.91x | 806.84x | 1105.61x |
| Aquestive Therapeutics, Inc. (AQST)vs › | $574.01M | 9.88x | 11.75x | 7.27x | 5.37x |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $552.40M | N/A | N/A | N/A | N/A |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $549.33M | 64.50x | 53.58x | 21.24x | 46.54x |
| OrthoPediatrics Corp. (KIDS)vs › | $587.91M | 2.62x | 2.20x | 3.12x | 5.45x |
| Nuvectis Pharma, Inc. (NVCT)vs › | $550.37M | N/A | N/A | N/A | N/A |
| Fulgent Genetics, Inc. (FLGT)vs › | $593.40M | 1.78x | 1.86x | 1.97x | 1.94x |
| Phathom Pharmaceuticals, Inc. (PHAT)vs › | $540.42M | 2.19x | 5.65x | 62.35x | 62.35x |
Enterprise Value (EV) = Market Cap + Total Debt - Cash
Sales = Total Revenue (TTM)
EV/Sales is commonly used because:
Note: EV/Sales does not include margin, debt maturity, cash conversion, or growth durability by itself.
EV/Sales = Enterprise Value / Revenue (TTM)
Enterprise value to sales compares total company value to revenue, useful across capital structures and for unprofitable companies.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/SALES RATIO |
|---|---|
| 2026-10-05 | 30.23x |
| 2026-10-02 | 29.99x |
| 2026-10-01 | 30.83x |
| 2026-09-30 | 31.91x |
| 2026-09-29 | 32.27x |
| 2026-09-28 | 31.55x |
| 2026-09-25 | 31.67x |
| 2026-09-24 | 32.27x |
| 2026-09-23 | 32.63x |
| 2026-09-22 | 34.54x |
| 2026-09-21 | 32.39x |
| 2026-09-18 | 32.39x |
| 2026-09-17 | 33.11x |
| 2026-09-16 | 32.51x |
| 2026-09-15 | 31.55x |
| 2026-09-14 | 37.65x |
| 2026-09-11 | 38.73x |
| 2026-09-10 | 39.45x |
| 2026-09-09 | 41.72x |
| 2026-09-08 | 43.03x |
| 2026-09-04 | 43.75x |
| 2026-09-03 | 43.39x |
| 2026-09-02 | 43.87x |
| 2026-09-01 | 43.27x |
| 2026-08-31 | 39.56x |
| 2026-08-28 | 37.77x |
| 2026-08-27 | 40.28x |
| 2026-08-26 | 39.09x |
| 2026-08-25 | 39.68x |
| 2026-08-24 | 38.73x |
| 2026-08-21 | 38.61x |
| 2026-08-20 | 38.73x |
| 2026-08-19 | 42.08x |
| 2026-08-18 | 39.92x |
| 2026-08-17 | 40.64x |
| 2026-08-14 | 39.56x |
| 2026-08-13 | 39.45x |
| 2026-08-12 | 41.12x |
| 2026-08-11 | 40.64x |
| 2026-08-10 | 40.52x |
| 2026-08-07 | 40.76x |
| 2026-08-06 | 16.08x |
| 2026-08-05 | 15.98x |
| 2026-08-04 | 15.83x |
| 2026-08-03 | 15.08x |
| 2026-07-31 | 14.73x |
| 2026-07-30 | 15.63x |
| 2026-07-29 | 15.08x |
| 2026-07-28 | 15.33x |
| 2026-07-27 | 15.48x |
| 2026-07-24 | 15.43x |
| 2026-07-23 | 15.88x |
| 2026-07-22 | 15.88x |
| 2026-07-21 | 16.33x |
| 2026-07-20 | 16.83x |
| 2026-07-17 | 17.32x |
| 2026-07-16 | 17.57x |
| 2026-07-15 | 17.62x |
| 2026-07-14 | 17.52x |
| 2026-07-13 | 17.72x |
| 2026-07-10 | 18.02x |
| 2026-07-09 | 19.02x |
| 2026-07-08 | 18.37x |
| 2026-07-07 | 18.42x |
| 2026-07-06 | 18.27x |
| 2026-07-02 | 18.32x |
| 2026-07-01 | 17.22x |
| 2026-06-30 | 17.97x |
| 2026-06-29 | 17.92x |
| 2026-06-26 | 16.23x |
| 2026-06-25 | 15.58x |
| 2026-06-24 | 15.83x |
| 2026-06-23 | 14.98x |
| 2026-06-22 | 14.43x |
| 2026-06-18 | 13.98x |
| 2026-06-17 | 14.03x |
| 2026-06-16 | 13.88x |
| 2026-06-15 | 14.43x |
| 2026-06-12 | 14.28x |
| 2026-06-11 | 14.13x |
| 2026-06-10 | 13.78x |
| 2026-06-09 | 14.13x |
| 2026-06-08 | 13.93x |
| 2026-06-05 | 14.23x |
| 2026-06-04 | 15.13x |
| 2026-06-03 | 15.33x |
| 2026-06-02 | 15.03x |
| 2026-06-01 | 16.48x |
| 2026-05-29 | 17.22x |
| 2026-05-28 | 17.77x |
| 2026-05-27 | 18.27x |
| 2026-05-26 | 17.67x |
| 2026-05-22 | 18.02x |
| 2026-05-21 | 18.02x |
| 2026-05-20 | 17.82x |
| 2026-05-19 | 17.42x |
| 2026-05-18 | 16.73x |
| 2026-05-15 | 17.27x |
| 2026-05-14 | 18.12x |
| 2026-05-13 | 18.17x |
| 2026-05-12 | 18.62x |
| 2026-05-11 | 18.52x |
| 2026-05-08 | 19.12x |
| 2026-05-07 | 8.82x |
| 2026-05-06 | 9.11x |
| 2026-05-05 | 9.00x |
| 2026-05-04 | 9.22x |
| 2026-05-01 | 9.22x |
| 2026-04-30 | 9.31x |
| 2026-04-29 | 8.93x |
| 2026-04-28 | 9.09x |
| 2026-04-27 | 9.47x |
| 2026-04-24 | 9.72x |
| 2026-04-23 | 9.83x |
| 2026-04-22 | 10.19x |
| 2026-04-21 | 10.52x |
| 2026-04-20 | 10.81x |
| 2026-04-17 | 10.65x |
| 2026-04-16 | 10.81x |
| 2026-04-15 | 10.07x |
| 2026-04-14 | 10.03x |
| 2026-04-13 | 9.69x |
| 2026-04-10 | 9.69x |
| 2026-04-09 | 9.36x |
| 2026-04-08 | 9.38x |
| 2026-04-07 | 9.49x |
| 2026-04-06 | 9.72x |
| 2026-04-02 | 10.07x |
| 2026-04-01 | 10.07x |
| 2026-03-31 | 10.39x |
| 2026-03-30 | 9.74x |
| 2026-03-27 | 9.98x |
| 2026-03-26 | 9.76x |
| 2026-03-25 | 9.31x |
| 2026-03-24 | 9.36x |
| 2026-03-23 | 9.85x |
| 2026-03-20 | 9.83x |
| 2026-03-19 | 10.57x |
| 2026-03-18 | 9.72x |
| 2026-03-17 | 12.06x |
| 2026-03-16 | 9.55x |
| 2026-03-13 | 6.54x |
| 2026-03-12 | 6.82x |
| 2026-03-11 | 6.83x |
| 2026-03-10 | 6.83x |
| 2026-03-09 | 7.05x |
| 2026-03-06 | 6.54x |
| 2026-03-05 | 6.67x |
| 2026-03-04 | 7.11x |
| 2026-03-03 | 6.73x |
| 2026-03-02 | 7.50x |
| 2026-02-27 | 7.55x |
| 2026-02-26 | 7.71x |
| 2026-02-25 | 8.14x |
| 2026-02-24 | 7.65x |
| 2026-02-23 | 7.85x |
| 2026-02-20 | 7.63x |
| 2026-02-19 | 7.69x |
| 2026-02-18 | 7.60x |
| 2026-02-17 | 7.40x |
| 2026-02-13 | 7.47x |
| 2026-02-12 | 7.63x |
| 2026-02-11 | 7.82x |
| 2026-02-10 | 7.78x |
| 2026-02-09 | 8.03x |
| 2026-02-06 | 7.98x |
| 2026-02-05 | 7.36x |
| 2026-02-04 | 7.98x |
| 2026-02-03 | 8.56x |
| 2026-02-02 | 8.59x |
| 2026-01-30 | 8.01x |
| 2026-01-29 | 8.08x |
| 2026-01-28 | 8.32x |
| 2026-01-27 | 8.36x |
| 2026-01-26 | 7.50x |
| 2026-01-23 | 7.79x |
| 2026-01-22 | 8.05x |
| 2026-01-21 | 7.43x |
| 2026-01-20 | 7.55x |
| 2026-01-16 | 7.58x |
| 2026-01-15 | 5.92x |
| 2026-01-14 | 5.99x |
| 2026-01-13 | 5.69x |
| 2026-01-12 | 6.05x |
| 2026-01-09 | 6.07x |
| 2026-01-08 | 5.93x |
| 2026-01-07 | 5.99x |
| 2026-01-06 | 5.76x |
| 2026-01-05 | 5.73x |
| 2026-01-02 | 5.92x |
| 2025-12-31 | 5.93x |
| 2025-12-30 | 5.79x |
| 2025-12-29 | 5.83x |
| 2025-12-26 | 6.12x |
| 2025-12-24 | 6.14x |
| 2025-12-23 | 5.85x |
| 2025-12-22 | 5.73x |
| 2025-12-19 | 5.56x |
| 2025-12-18 | 5.38x |
| 2025-12-17 | 5.72x |
| 2025-12-16 | 5.92x |
| 2025-12-15 | 5.75x |
| 2025-12-12 | 5.83x |
| 2025-12-11 | 5.64x |
| 2025-12-10 | 5.41x |
| 2025-12-09 | 5.40x |
| 2025-12-08 | 5.37x |
| 2025-12-05 | 5.48x |
| 2025-12-04 | 5.67x |
| 2025-12-03 | 5.56x |
| 2025-12-02 | 5.28x |
| 2025-12-01 | 5.98x |
| 2025-11-28 | 5.96x |
| 2025-11-26 | 5.88x |
| 2025-11-25 | 5.77x |
| 2025-11-24 | 5.51x |
| 2025-11-21 | 5.38x |
| 2025-11-20 | 5.22x |
| 2025-11-19 | 5.02x |
| 2025-11-18 | 5.06x |
| 2025-11-17 | 4.90x |
| 2025-11-14 | 5.38x |
| 2025-11-13 | 5.35x |
| 2025-11-12 | 5.89x |
| 2025-11-11 | 5.70x |
| 2025-11-10 | 5.83x |
| 2025-11-07 | 5.01x |
| 2025-11-06 | 3.53x |
| 2025-11-05 | 3.55x |
| 2025-11-04 | 3.44x |
| 2025-11-03 | 3.30x |
| 2025-10-31 | 2.97x |
| 2025-10-30 | 2.75x |
| 2025-10-29 | 2.68x |
| 2025-10-28 | 2.74x |
| 2025-10-27 | 2.77x |
| 2025-10-24 | 2.68x |
| 2025-10-23 | 2.72x |
| 2025-10-22 | 2.80x |
| 2025-10-21 | 3.01x |
| 2025-10-20 | 3.12x |
| 2025-10-17 | 2.63x |
| 2025-10-16 | 2.70x |
| 2025-10-15 | 2.82x |
| 2025-10-14 | 2.83x |
| 2025-10-13 | 2.81x |
| 2025-10-10 | 2.77x |
| 2025-10-09 | 2.86x |
| 2025-10-08 | 2.78x |
| 2025-10-07 | 2.75x |
| 2025-10-06 | 2.70x |
| 2025-10-03 | 2.72x |
| 2025-10-02 | 2.70x |
| 2025-10-01 | 2.77x |
| 2025-09-30 | 2.62x |
| 2025-09-29 | 2.66x |
| 2025-09-26 | 2.35x |
| 2025-09-25 | 2.30x |
| 2025-09-24 | 1.91x |
| 2025-09-23 | 1.63x |
Showing the most recent 260 of 2,583 data points. The chart above shows the full history.
